Oncosil first primary targets are solid tumours in pancreatic and liver
It can also deliver to other solid tumours in other parts of the body
It goes directly into the tumour cooks and kills from the inside over a period of time
Sitrtex does not inside the tumour
Market cap still at 2.2 billion on not delivering all the end points
- Forums
- ASX - By Stock
- Impact of Sirflox failure to meet primary end point
Oncosil first primary targets are solid tumours in pancreatic...
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSL (ASX) to my watchlist
|
|||||
Last
1.4¢ |
Change
0.002(16.7%) |
Mkt cap ! $52.97M |
Open | High | Low | Value | Volume |
1.3¢ | 1.4¢ | 1.2¢ | $170.2K | 13.08M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 1581235 | 1.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.4¢ | 9880504 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 1581235 | 0.013 |
11 | 4873400 | 0.012 |
12 | 13504785 | 0.011 |
12 | 5445000 | 0.010 |
13 | 9017045 | 0.009 |
Price($) | Vol. | No. |
---|---|---|
0.014 | 9662504 | 8 |
0.015 | 10207096 | 10 |
0.016 | 829168 | 2 |
0.017 | 5088882 | 2 |
0.018 | 471540 | 2 |
Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online